Teladoc Health Reports Q1 EPS Miss and Revenue Beat
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy TDOC?
Source: seekingalpha
- Earnings Performance: Teladoc Health reported a Q1 GAAP EPS of -$0.36, missing expectations by $0.02, indicating ongoing challenges in profitability that may affect investor confidence.
- Revenue Growth: Despite the EPS miss, Teladoc's revenue reached $613.84 million, exceeding analyst expectations by $3.25 million, suggesting potential for growth in customer demand and market share.
- Future Guidance: The company's guidance for 2026 includes consensus estimates, reflecting management's confidence in future performance, although current profitability issues may influence long-term investor decisions.
- Market Reaction: Following the Q1 EPS miss, Teladoc's stock price declined, indicating market concerns about the company's short-term financial performance, which may lead investors to reassess their investment strategies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TDOC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TDOC
Wall Street analysts forecast TDOC stock price to rise
15 Analyst Rating
3 Buy
12 Hold
0 Sell
Hold
Current: 6.000
Low
7.50
Averages
8.91
High
12.00
Current: 6.000
Low
7.50
Averages
8.91
High
12.00
About TDOC
Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Teladoc Health Q1 Earnings Report Analysis
- Earnings Performance: Teladoc Health reported a Q1 GAAP EPS of -$0.36, missing expectations by $0.02, indicating pressure on profitability, while revenue of $613.84 million, down 2.5% year-over-year, exceeded market expectations by $3.25 million, reflecting the company's resilience amid market fluctuations.
- 2026 Outlook: The company forecasts full-year 2026 revenue between $2.481 billion and $2.576 billion, slightly below the market consensus of $2.51 billion, with adjusted EBITDA expected to range from $267 million to $306 million, and net loss per share projected between -$1.05 and -$0.75, highlighting uncertainty in future profitability.
- Cash Flow Situation: Teladoc anticipates free cash flow for 2026 to be between $130 million and $170 million, demonstrating some cash generation capability despite challenges, which may support future investments and operations.
- User Growth Expectations: The expected number of U.S. Integrated Care Members is projected to be between 97 million and 100 million, indicating the company's efforts to expand its user base, which, despite a challenging overall market environment, still holds potential for increasing market share.
See More
Teladoc Health Reports Q1 EPS Miss and Revenue Beat
- Earnings Performance: Teladoc Health reported a Q1 GAAP EPS of -$0.36, missing expectations by $0.02, indicating ongoing challenges in profitability that may affect investor confidence.
- Revenue Growth: Despite the EPS miss, Teladoc's revenue reached $613.84 million, exceeding analyst expectations by $3.25 million, suggesting potential for growth in customer demand and market share.
- Future Guidance: The company's guidance for 2026 includes consensus estimates, reflecting management's confidence in future performance, although current profitability issues may influence long-term investor decisions.
- Market Reaction: Following the Q1 EPS miss, Teladoc's stock price declined, indicating market concerns about the company's short-term financial performance, which may lead investors to reassess their investment strategies.
See More
Tech Giants Show Mixed Earnings Performance
- Google Earnings Beat: Alphabet reported first-quarter revenue of $109.9 billion, exceeding the $107.2 billion expected by analysts, with cloud revenue surging 63% year-over-year to $20.02 billion, indicating strong market demand and competitive advantage.
- Microsoft Spending Miss: Microsoft reported $31.9 billion in capital expenditures for its fiscal third quarter, falling short of the $34.9 billion consensus among analysts, although it posted earnings and revenue beats, reflecting a cautious investment strategy.
- Amazon Capital Expenditures Rise: Amazon's first-quarter revenue reached $181.52 billion, surpassing expectations, but capital expenditures totaled $44.2 billion, slightly above the $43.39 billion forecast, highlighting the company's ongoing expansion plans.
- Meta User Growth Misses: Meta's first-quarter capital expenditures were $19.84 billion, below the StreetAccount forecast of $27.57 billion, despite beating revenue expectations, indicating challenges in user growth.
See More
Teladoc Health Q1 Earnings Miss Expectations, Stock Drops 5%
- Earnings Report Disappointment: Teladoc Health reported a Q1 GAAP EPS loss of -$0.36, missing expectations by $0.02, which led to a 5% drop in after-hours trading, indicating market concerns over its profitability.
- Revenue Decline: Although total revenue of $613.84 million beat expectations by $3.25 million, it represented a 2% year-over-year decline, with the BetterHelp segment experiencing a 9% drop to $218.4 million, highlighting challenges in core operations.
- Deteriorating Cash Position: As of March 31, 2025, Teladoc's cash and cash equivalents stood at approximately $750.7 million, a significant decrease from $1.2 billion at the end of Q1 2025, indicating pressure on the company's financial management.
- Stable Future Outlook: Teladoc reaffirmed its 2026 revenue guidance midpoint of $2.481 billion to $2.576 billion, although the projected net loss range of -$1.05 to -$0.75 billion is below the consensus estimate of $0.95 billion, reflecting the company's confidence in its future.
See More
Teladoc Health Q1 Earnings Outlook Shows Mixed Signals
- Earnings Expectations: Teladoc Health anticipates a 26% improvement in Q1 loss, with revenue projected to decline by 3% to $610.59 million, reflecting cautious market sentiment as analysts have not revised earnings or revenue upward.
- BetterHelp Performance: BetterHelp's revenue fell 9% in 2025, but following the acquisition of UpLift, insurance revenue is expected to grow to $75 million to $90 million in 2026, indicating a potential shift in business model.
- Integrated Care Growth: The integrated care segment is forecasted to grow revenue by 0.4% to 3.9% in 2026, with U.S. integrated care members expected to reach between 97 million and 100 million, demonstrating stable market demand.
- PulseAI Potential: The launch of PulseAI offers Teladoc an AI-based patient classification system that identifies chronic condition deterioration, enhancing its value proposition and potentially transforming traditional healthcare models.
See More
Teladoc and PayPal Face Challenges and Opportunities
- Teladoc's Health Status: Teladoc has significantly lagged the market with over an 80% decline in stock price over the past five years, despite having more than 100 million members on its platform, facing dual pressures from intense competition and high customer acquisition costs that have kept it unprofitable.
- International Expansion Efforts: While Teladoc has seen good revenue growth internationally, its slow progress in expanding third-party coverage for BetterHelp may hinder its future market appeal and growth potential.
- PayPal's Market Position: PayPal benefited from the rapid growth of e-commerce during the pandemic, ending 2025 with 439 million active accounts and a total payment volume of $1.79 trillion, although growth has slowed, its brand trust and network effects still provide a competitive edge.
- Digital Advertising Opportunities: PayPal is actively expanding into digital advertising, leveraging its extensive consumer shopping data to assist businesses in targeted ad placements, a high-margin opportunity that could enhance the company's revenue and earnings in the long run.
See More
Teladoc Health Q1 Earnings Report Analysis
- Earnings Performance: Teladoc Health reported a Q1 GAAP EPS of -$0.36, missing expectations by $0.02, indicating pressure on profitability, while revenue of $613.84 million, down 2.5% year-over-year, exceeded market expectations by $3.25 million, reflecting the company's resilience amid market fluctuations.
- 2026 Outlook: The company forecasts full-year 2026 revenue between $2.481 billion and $2.576 billion, slightly below the market consensus of $2.51 billion, with adjusted EBITDA expected to range from $267 million to $306 million, and net loss per share projected between -$1.05 and -$0.75, highlighting uncertainty in future profitability.
- Cash Flow Situation: Teladoc anticipates free cash flow for 2026 to be between $130 million and $170 million, demonstrating some cash generation capability despite challenges, which may support future investments and operations.
- User Growth Expectations: The expected number of U.S. Integrated Care Members is projected to be between 97 million and 100 million, indicating the company's efforts to expand its user base, which, despite a challenging overall market environment, still holds potential for increasing market share.
See More
Teladoc Health Reports Q1 EPS Miss and Revenue Beat
- Earnings Performance: Teladoc Health reported a Q1 GAAP EPS of -$0.36, missing expectations by $0.02, indicating ongoing challenges in profitability that may affect investor confidence.
- Revenue Growth: Despite the EPS miss, Teladoc's revenue reached $613.84 million, exceeding analyst expectations by $3.25 million, suggesting potential for growth in customer demand and market share.
- Future Guidance: The company's guidance for 2026 includes consensus estimates, reflecting management's confidence in future performance, although current profitability issues may influence long-term investor decisions.
- Market Reaction: Following the Q1 EPS miss, Teladoc's stock price declined, indicating market concerns about the company's short-term financial performance, which may lead investors to reassess their investment strategies.
See More
Tech Giants Show Mixed Earnings Performance
- Google Earnings Beat: Alphabet reported first-quarter revenue of $109.9 billion, exceeding the $107.2 billion expected by analysts, with cloud revenue surging 63% year-over-year to $20.02 billion, indicating strong market demand and competitive advantage.
- Microsoft Spending Miss: Microsoft reported $31.9 billion in capital expenditures for its fiscal third quarter, falling short of the $34.9 billion consensus among analysts, although it posted earnings and revenue beats, reflecting a cautious investment strategy.
- Amazon Capital Expenditures Rise: Amazon's first-quarter revenue reached $181.52 billion, surpassing expectations, but capital expenditures totaled $44.2 billion, slightly above the $43.39 billion forecast, highlighting the company's ongoing expansion plans.
- Meta User Growth Misses: Meta's first-quarter capital expenditures were $19.84 billion, below the StreetAccount forecast of $27.57 billion, despite beating revenue expectations, indicating challenges in user growth.
See More
Teladoc Health Q1 Earnings Miss Expectations, Stock Drops 5%
- Earnings Report Disappointment: Teladoc Health reported a Q1 GAAP EPS loss of -$0.36, missing expectations by $0.02, which led to a 5% drop in after-hours trading, indicating market concerns over its profitability.
- Revenue Decline: Although total revenue of $613.84 million beat expectations by $3.25 million, it represented a 2% year-over-year decline, with the BetterHelp segment experiencing a 9% drop to $218.4 million, highlighting challenges in core operations.
- Deteriorating Cash Position: As of March 31, 2025, Teladoc's cash and cash equivalents stood at approximately $750.7 million, a significant decrease from $1.2 billion at the end of Q1 2025, indicating pressure on the company's financial management.
- Stable Future Outlook: Teladoc reaffirmed its 2026 revenue guidance midpoint of $2.481 billion to $2.576 billion, although the projected net loss range of -$1.05 to -$0.75 billion is below the consensus estimate of $0.95 billion, reflecting the company's confidence in its future.
See More
Teladoc Health Q1 Earnings Outlook Shows Mixed Signals
- Earnings Expectations: Teladoc Health anticipates a 26% improvement in Q1 loss, with revenue projected to decline by 3% to $610.59 million, reflecting cautious market sentiment as analysts have not revised earnings or revenue upward.
- BetterHelp Performance: BetterHelp's revenue fell 9% in 2025, but following the acquisition of UpLift, insurance revenue is expected to grow to $75 million to $90 million in 2026, indicating a potential shift in business model.
- Integrated Care Growth: The integrated care segment is forecasted to grow revenue by 0.4% to 3.9% in 2026, with U.S. integrated care members expected to reach between 97 million and 100 million, demonstrating stable market demand.
- PulseAI Potential: The launch of PulseAI offers Teladoc an AI-based patient classification system that identifies chronic condition deterioration, enhancing its value proposition and potentially transforming traditional healthcare models.
See More
Teladoc and PayPal Face Challenges and Opportunities
- Teladoc's Health Status: Teladoc has significantly lagged the market with over an 80% decline in stock price over the past five years, despite having more than 100 million members on its platform, facing dual pressures from intense competition and high customer acquisition costs that have kept it unprofitable.
- International Expansion Efforts: While Teladoc has seen good revenue growth internationally, its slow progress in expanding third-party coverage for BetterHelp may hinder its future market appeal and growth potential.
- PayPal's Market Position: PayPal benefited from the rapid growth of e-commerce during the pandemic, ending 2025 with 439 million active accounts and a total payment volume of $1.79 trillion, although growth has slowed, its brand trust and network effects still provide a competitive edge.
- Digital Advertising Opportunities: PayPal is actively expanding into digital advertising, leveraging its extensive consumer shopping data to assist businesses in targeted ad placements, a high-margin opportunity that could enhance the company's revenue and earnings in the long run.
See More
